{"acquired gene mutation": 1783.41, "cardiac failure": 5.3, "cardiomyopathy": 7.59, "cardiotoxicity": 29.34, "deep vein thrombosis": 2.34, "disease progression": 6.24, "drug resistance": 145.77, "egfr gene mutation": 998.03, "electrocardiogram qt prolonged": 5.78, "general physical health deterioration": 2.33, "interstitial lung disease": 18.14, "maligt neoplasm progression": 47.98, "maligt transformation": 1029.15, "metastases to bone": 24.4, "metastases to central nervous system": 72.87, "metastases to liver": 23.55, "metastases to lung": 26.67, "metastases to lymph nodes": 24.36, "metastases to meninges": 343.2, "metastasis": 24.0, "mucosal inflammation": 8.96, "myelosuppression": 3.53, "off label use": 2.46, "paronychia": 108.29, "platelet count decreased": 2.66, "pleural effusion": 7.08, "pneumonitis": 52.72, "pulmonary embolism": 3.76, "respiratory failure": 4.76, "skin toxicity": 28.33, "thrombocytopenia": 5.02}